Journal Information

Statistics

Follow this link to access the full text of the article

Scientific Letter
Osimertinib for the Treatment of EGFR Mutation-Positive Lung Adenocarcinoma Complicated With Dermatomyositis
El osimertinib como tratamiento del adenocarcinoma de pulmón con mutación positiva del EGFR complicado con dermatomiositis
Masahiro Yamasakia,
Corresponding author
myamasanjp@yahoo.co.jp

Corresponding author.
, Naoko Matsumotoa, Shota Nakanob, Kazuma Kawamotoa, Masaya Taniwakia, Yusuke Izumia, Masaya Otoharaa, Shinji Nabeshimac, Nobuyuki Ohashid, Noboru Hattoric
a Department of Respiratory Disease, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Naka-ku, Hiroshima, Japan
b Department of Rheumatology, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Naka-ku, Hiroshima, Japan
c Department of Molecular and Internal Medicine, Institute of Biomedical & Health Sciences, Hiroshima University, Minami-ku, Hiroshima, Japan
d Ohashi Clinic, Naka-ku, Hiroshima, Japan
Read
2044
Times
was read the article
752
Total PDF
1292
Total HTML
Share statistics
Article information
ISSN: 15792129
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 6 3 13 16
2025 5 109 23 132
2025 4 96 22 118
2025 3 97 15 112
2025 2 78 20 98
2025 1 48 28 76
2024 12 40 18 58
2024 11 48 33 81
2024 10 34 15 49
2024 9 35 14 49
2024 8 58 32 90
2024 7 45 20 65
2024 6 42 23 65
2024 5 65 30 95
2024 4 32 25 57
2024 3 37 24 61
2024 2 44 24 68
2023 3 10 4 14
2023 2 30 17 47
2023 1 27 25 52
2022 12 36 30 66
2022 11 41 21 62
2022 10 40 31 71
2022 9 19 21 40
2022 8 29 45 74
2022 7 28 38 66
2022 6 24 29 53
2022 5 24 26 50
2022 4 29 36 65
2022 3 26 33 59
2022 2 15 17 32
2021 3 2 0 2
2020 12 1 0 1
Show all

Follow this link to access the full text of the article

Archivos de Bronconeumología

Are you a health professional able to prescribe or dispense drugs?